Andrew Gotschall
Research Associate
Department: Biomedical Engineering
About Me:
Andrew Gotschall is a research associate who graduated from the biomedical science undergraduate major within The Ohio State University College of Medicine (OSUCOM). At the age of 14, Andrew was diagnosed with type 1 diabetes, which led him to Dr. Daniel Gallego-Perez’s Precision Nanomedicine Laboratory to conduct type 1 diabetes research. Before graduating in May of 2024, Andrew successfully defended his honors thesis titled “Non-viral Direct Cell Reprogramming Methods Aiming to Rescue Glycemic Control in Type 1 Diabetes” to achieve Honors in Medicine and Honors Research Distinction. His dedication to and leadership on the β cell reprogramming project has yielded him BMES Honorable Mention in Engineering Endocrine Tissue Function, 1st place and audience choice at the OSUCOM Annual Education Symposium 3-minute thesis competition, 1st place at the Engineering in Healthcare Symposium, and travel awards at OSUCOM Trainee Research Day and the Preventative Health of Adipose Tissue Symposium. After a gap year of research, Andrew plans to attend a medical scientist training program (MSTP) to acquire his MD/PhD. Ultimately, he wants to become a physician who conducts translational type 1 diabetes research.
Links:
X (Twiter): https://x.com/andrewgotschall
